Join to View Full Profile
111 E 210th StreetBronx, NY 10467
Phone+1 718-430-4288
Fax+1 718-430-8551
Are you Dr. Qureshi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Irfan Qureshi, MD is a board certified neurologist in Bronx, New York. He is currently licensed to practice medicine in New York. He is an Assistant Professor at Albert Einstein College of Medicine.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 2003 - 2006
Johns Hopkins UniversityInternship, Internal Medicine, 2002 - 2003
Albert Einstein College of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2006 - 2027
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 10 citationsNervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome.Harnadar Anand, Victoria Ende, Gurinder Singh, Irfan A. Qureshi, Timothy Q. Duong
Frontiers in Neuroscience. 2021-08-27 - Frontiers in neuroepigeneticsIrfan A. Qureshi, Mark F. Mehler
Neurobiology of Disease. 2021-03-12 - 26 citationsPredicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques.Ali Ezzati, Danielle J Harvey, Christian G. Habeck, Ashkan Golzar, Irfan A. Qureshi
Journal of Alzheimer's Disease. 2020-01-01
Press Mentions
Biohaven's Phase 3 Trial, and Other News: The Good, Bad and Ugly of BiopharmaJuly 22nd, 2020
Biohaven's Verdiperstat, an Oral Myeloperoxidase Inhibitor, Selected for Platform Trial Collaboration at Massachusetts General Hospital's Healey & AMG Center for Amyotrophic Lateral Sclerosis (ALS)January 22nd, 2020- Biohaven Provides Update on Phase 2/3 Alzheimers Disease Clinical Trial: Over 400 Patients EnrolledAugust 12th, 2019
- Join now to see all
